| authorizations: |
registration not required
|
| accessURL: |
http://www.iedb.org/reference/1026940 |
| landingPage: |
http://www.iedb.org/assay/2012299 |
| type: |
Literature
|
| publicationVenue: |
Am J Clin Exp Immunol
|
| dates: |
2013
|
| study type: | b cell assays |
| subject species: | Homo sapiens |
| fullName: |
Emanuel Calenoff
|
| method: |
in vivo assay
|
| name: |
Mimotopic peptide immunotherapy for the treatment of multiple sclerosis, an inflammatory autoimmune disease.
|
| description: |
Treatment with the epitope reduced serum reactivity to the epitope, starting in the first weeks of therapy and continuing to week 35.
|
| name: |
iedb
|
| homePage: |
http://www.iedb.org |